Med X Units (Proposed)
MXRX0.000
Close 12/19, 16:00（ET）Quotes delayed by 15 min
--Market Cap
--P/E TTM
More Details of Med X Units (Proposed) Company
Med-X, Inc. is a provider of biological pest control solutions. The Company is engaged in developing all-natural alternative solutions to the outdated poisonous chemicals and harmful pharmaceutical products often used in pest control and pain management. Its brands include Nature-Cide, Thermal-Aid, and Malibu Brands. Nature-Cide products are all-natural essential oil blends of indoor and outdoor pesticide/insecticide/repellent. Thermal-Aid, Thermal-Aid Zoo and the Thermal-Aid Headache Relief System are natural heating/cooling pain and physical therapy products for painful ailments affecting adults, children and animals. Malibu Brands are all-natural essential oils, including hemp and cannabidiol (CBD) oil products. It also operates the MJT Network through the Company’s online media platform, www.marijuanatimes.org. The Company operates through one segment: online sales. Its online sales consist of the channels, such as Ecommerce/Online, Distributors, and Digital Advertising.
Med X Units (Proposed) Info
Ticker SymbolMXRX
Company nameMed X Inc
IPO date- -
CEOMills (Matthew)
Number of employees- -
Security typeUnit
Fiscal year-end- -
Address8236 Remmet Ave.
CityCANOGA PARK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code91304
Phone18183492870
Websitehttps://www.medx-rx.com
Ticker SymbolMXRX
IPO date- -
CEOMills (Matthew)
Company Executives of Med X Units (Proposed)
Name
Name/Position
Position
Shareholding
Change
Jennifer Mills
Jennifer Mills
President, Executive Vice President, Corporate Secretary, Director
President, Executive Vice President, Corporate Secretary, Director
--
--
Dr. Allan Kurtz
Dr. Allan Kurtz
Independent Director
Independent Director
--
--
Ronald Tchorzewski
Ronald Tchorzewski
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Fred Dashiell, Jr.
Mr. Fred Dashiell, Jr.
Independent Director
Independent Director
--
--
Matthew Mills
Matthew Mills
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
David Toomey
David Toomey
Chief Scientific Officer
Chief Scientific Officer
--
--
Morton Hyson
Morton Hyson
Independent Director
Independent Director
--
--
Nick Phillips
Nick Phillips
Chief Media Officer
Chief Media Officer
--
--
Mr. Michael J. Kuntz
Mr. Michael J. Kuntz
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Jennifer Mills
Jennifer Mills
President, Executive Vice President, Corporate Secretary, Director
President, Executive Vice President, Corporate Secretary, Director
--
--
Dr. Allan Kurtz
Dr. Allan Kurtz
Independent Director
Independent Director
--
--
Ronald Tchorzewski
Ronald Tchorzewski
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Fred Dashiell, Jr.
Mr. Fred Dashiell, Jr.
Independent Director
Independent Director
--
--
Matthew Mills
Matthew Mills
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
David Toomey
David Toomey
Chief Scientific Officer
Chief Scientific Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Sep 23
Currency: USDUpdated: Tue, Sep 23
FY2023Q1
FY2022
FY2022Q2
FY2022Q1
FY2021
FY2021Q2
FY2020
By BusinessUSD
Name
Revenue
Proportion
Thermal Aid
235.47K
59.68%
Nature Cide
146.63K
37.16%
Malibu brands
12.44K
3.15%
Advertising
0.00
0.00%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Thermal Aid
235.47K
59.68%
Nature Cide
146.63K
37.16%
Malibu brands
12.44K
3.15%
Advertising
0.00
0.00%
Shareholding Stats
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Reporting Period
No. of institutions
Shares Held
Proportion
Change
No Data
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
No Data
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Med X Units (Proposed)?
The top five shareholders of Med X Units (Proposed) are:
What are the top three shareholder types of Med X Units (Proposed)?
The top three shareholder types of Med X Units (Proposed) are:
Other
Other
How many institutions hold shares of Med X Units (Proposed) (MXRX)?
As of --, -- institutions hold shares of Med X Units (Proposed), with a combined market value of approximately --, accounting for --% of the total shares. Compared to --, institutional shareholding has increased by --.
What is the biggest source of revenue for Med X Units (Proposed)?
In FY2023Q1, the Thermal Aid business generated the highest revenue for Med X Units (Proposed), amounting to 235.47K and accounting for 59.68% of total revenue.
